Form 8-K Filing for Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc. reported changes in its board and executive officers. Mr. Ajay Kumar Dhadha resigned as Chairman of the Board and Director effective June 30, 2026. Mr. Guy Ofir resigned as Chief Financial Officer, General Counsel, and Director effective July 16, 2026. Both resignations were voluntary and not due to any disagreements with the company. Effective July 16, 2026, Mr. Uri Tadelis was appointed as the new Chief Financial Officer. The report was filed on July 16, 2026.